The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

The main goals of chronic hepatitis B treatment should be the long-term suppression of viral replication to minimize disease progression and the risk for the development of hepatocellular carcinoma.

Some commonly used anti-HIV drugs are also active against hepatitis B and should be included in your HIV treatment combination. These drugs must be used carefully: don’t use one to treat hepatitis B ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

which have been shown to be even more potent inhibitors of hepatitis B replication. The large experience gained from treating HIV infection has shown that combination therapy is preferable to ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

These findings promise new hope for patients undergoing long-term antiviral treatment for hepatitis B. Reference: Yim HJ, Seo YS, Kim JH, et al. Switching to besifovir in patients with chronic ...

“Without diagnosis and monitoring to initiate treatment where indicated, in many cases hepatitis B leads to severe liver disease, so early detection is critical. Hepatitis B continues to be the ...

Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...